IL1B and neuropathy: Fourteen days after neuropathy, as expected, the CCI group showed an increased expression of IL-1β (F(3.20) = 8.860, p = 0.0004; Figure 3B) and inhibited expression of IL-4 (F(3.20) = 117.0, p < 0.0001; Figure 3C), IL-10 (F(3.20) = 7.666, p = 0.0008; Figure 3E), and IL-17A (F(3.20) = 5.091, p = 0.0072; Figure 3F) in the sciatic nerve, when compared to the FOP control group.